Skip to main content Accessibility help

The efficacy of group cognitive-behavioural therapy plus duloxetine for generalised anxiety disorder versus duloxetine alone

  • Zhi-Juan Xie (a1), Nan Han (a2), Samuel Law (a3), Zhi-Wen Li (a4), Shu-Yan Chen (a5), Ju-Ping Xiao (a6), Yi Zhang (a6), Bing-Ling Gao (a7), Si-Si Jiang (a7), Hui-Min Gao (a7) and Xue-Bing Huang (a7)...



To explore whether and how group cognitive-behavioural therapy (GCBT) plus medication differs from medication alone for the treatment of generalised anxiety disorder (GAD).


Hundred and seventy patients were randomly assigned to the GCBT plus duloxetine (n=89) or duloxetine group (n=81). The primary outcomes were Hamilton Anxiety Scale (HAMA) response and remission rates. The explorative secondary measures included score reductions from baseline in the HAMA total, psychic, and somatic anxiety subscales (HAMA-PA, HAMA-SA), the Hamilton Depression Scale, the Severity Subscale of Clinical Global Impression Scale, Global Assessment of Functioning, and the 12-item Short-Form Health Survey. Assessments were conducted at baseline, 4-week, 8-week, and 3-month follow-up.


At 4 weeks, HAMA response (GCBT group 57.0% vs. control group 24.4%, p=0.000, Cohen’s d=0.90) and remission rates (GCBT group 21.5% vs. control group 6.2%, p=0.004; d=0.51), and most secondary outcomes (all p<0.05, d=0.36−0.77) showed that the combined therapy was superior. At 8 weeks, all the primary and secondary significant differences found at 4 weeks were maintained with smaller effect sizes (p<0.05, d=0.32−0.48). At 3-month follow-up, the combined therapy was only significantly superior in the HAMA total (p<0.045, d=0.43) and HAMA-PA score reductions (p<0.001, d=0.77). Logistic regression showed superiority of the combined therapy for HAMA response rates [odds ratio (OR)=2.12, 95% confidence interval (CI) 1.02−4.42, p=0.04] and remission rates (OR=2.80, 95% CI 1.27−6.16, p=0.01).


Compared with duloxetine alone, GCBT plus duloxetine showed significant treatment response for GAD over a shorter period of time, particularly for psychic anxiety symptoms, which may suggest that GCBT was effective in changing cognitive style.


Corresponding author

Author for correspondence: Xue-Bing Huang, E-mail:


Hide All
American Psychiatric Association (APA ) (1987) Diagnostic and Statistical Manual of Mental Disorders, 3rd Edn, rev. Washington, DC: American Psychiatric Association.
American Psychiatric Association (APA) (1994) Diagnostic and Statistical Manual of Mental Disorders (DSM-IV), 4th Edn. Washington, DC: American Psychiatric Association.
Baldwin, DS, Hou, R, Gordon, R, Huneke, NT and Garner, M (2017) Pharmacotherapy in generalized anxiety disorder: novel experimental medicine models and emerging drug targets. CNS Drugs 31, 307317.
Beck, JG and Coffey, SF (2005) Group Cognitive Behavioral Treatment for PTSD: Treatment of Motor Vehicle Accident Survivors. Cognitive and Behavioral Practice 12, 267277.
Behar, E, DiMarco, ID, Hekler, EB, Mohlman, J and Staples, AM (2009) Current theoretical models of generalized anxiety disorder (GAD): conceptual review and treatment implications. Journal of Anxiety Disorders 23, 10111023.
Bereza, BG, Machado, M and Einarson, TR (2009) Systematic review and quality assessment of economic evaluations and quality-of-life studies related to generalized anxiety disorder. Clinical Therapeutics 31, 12791308.
Bieling, JP, McCabe, ER and Antony, MM (2015) Cognitive Behavioural Therapy in Groups. New York: Guilford Press.
Black, DW (2006) Efficacy of combined pharmacotherapy and psychotherapy versus monotherapy in the treatment of anxiety disorders. CNS Spectrums 11, 2933.
Crits-Christoph, P, Newman, MG, Rickels, K, Gallop, R, Gibbons, MB, Hamilton, JL, Ring-Kurtz, S and Pastva, AM (2011) Combined medication and cognitive therapy for generalized anxiety disorder. Journal of Anxiety Disorders 25, 10871094.
Cuijpers, P, Cristea, IA, Karyotaki, E, Reijnders, M and Huibers, MJ (2016) How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence. World Psychiatry 15, 245258.
Cuijpers, P, Sijbrandij, M, Koole, SL, Andersson, G, Beekman, AT and Reynolds, CR (2014) Adding psychotherapy to antidepressant medication in depression and anxiety disorders: a meta-analysis. World Psychiatry 13, 5667.
Dugas, MJ, Ladouceur, R, Leger, E, Freeston, MH, Langlois, F, Provencher, MD and Boisvert, JM (2003) Group cognitive-behavioral therapy for generalized anxiety disorder: treatment outcome and long-term follow-up. Journal of Consulting and Clinical Psychology 71, 821825.
Dugas, MJ and Robichaud, M (2007) Cognitive-behavioral treatment for generalized anxiety disorder: From science to practice. Journal of Contemporary Psychotherapy 30, 149161.
Gersh, E, Hallford, DJ, Rice, SM, Kazantzis, N, Gersh, H, Gersh, B and McCarty, CA (2017). Systematic review and meta-analysis of dropout rates in individual psychotherapy for generalized anxiety disorder. Journal of Anxiety Disorders 52, 2533.
Guy, W (1976) The clinician global severity and impression scales. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: National Institute of Mental Health, 218222.
Hamilton, M (1959) The assessment of anxiety states by rating. British Journal of Medical Psychology 32, 5055.
Hamilton, M (1960) A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 23, 5662.
Han, HY, Yao, SM, Zhan-Jiang, LI, Guo, M, Zhao-Yan, FU, Zi-Yan, XU, Guo, ZH, Luo, J, Liu, J and Hospital, BA (2013) Cognitive-behavioral therapy components for generalized anxiety disorder: A Delphi Poll study. Chinese Mental Health Journal 27, Part 1, 410
Hoffman, DL, Dukes, EM and Wittchen, HU (2008) Human and economic burden of generalized anxiety disorder. Depression and Anxiety 25, 7290.
Hofmann, SG, Sawyer, AT, Korte, KJ and Smits, JA (2009) Is it Beneficial to Add Pharmacotherapy to Cognitive-Behavioral Therapy when Treating Anxiety Disorders? A Meta-Analytic Review. International Journal of Cognitive Therapy 2, 160175.
Hui, C and Zhihui, Y (2017) Group cognitive behavioral therapy targeting intolerance of uncertainty: a randomized trial for older Chinese adults with generalized anxiety disorder. Aging aand Mental Health 21, 12941302.
Katzman, MA (2009) Current considerations in the treatment of generalized anxiety disorder. CNS Drugs 23, 103120.
Katzman, MA, Bleau, P, Blier, P, Chokka, P, Kjernisted, K, Van Ameringen, M, Antony, MM, Bouchard, S, Brunet, A, Flament, M, Grigoriadis, S, Mendlowitz, S, O′Connor, K, Rabheru, K, Richter, PM, Robichaud, M and Walker, JR (2014) Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry 14 Suppl 1, S1.
Koen, N and Stein, DJ (2011) Pharmacotherapy of anxiety disorders: a critical review. Dialogues in Clinical Neuroscience 13, 423437.
Ladouceur, R, Dugas, MJ, Freeston, MH, Leger, E, Gagnon, F and Thibodeau, N (2000) Efficacy of a cognitive-behavioral treatment for generalized anxiety disorder: evaluation in a controlled clinical trial. Journal of Consulting and Clinical Psychology 68, 957964.
Luciani, JJ (2010) Self-Coaching: The Powerful Program to Beat Anxiety and Depression, 2nd Edn, Completely Revised and Updated. Hoboken, NJ: John Wiley & Sons Inc.
McHugh, RK, Whitton, SW, Peckham, AD, Welge, JA and Otto, MW (2013) Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review. The Journal of Clinical Psychiatry 74, 595602.
Olatunji, BO, Cisler, JM and Deacon, BJ (2010) Efficacy of cognitive behavioral therapy for anxiety disorders: a review of meta-analytic findings. Psychiatric Clinics of North America 33, 557577.
Pelletier, L, O′Donnell, S, McRae, L and Grenier, J (2017) The burden of generalized anxiety disorder in Canada. Health Promotion and Chronic Disease Prevention in Canada 37, 5462.
Perahia, DG, Pritchett, YL, Kajdasz, DK, Bauer, M, Jain, R, Russell, JM, Walker, DJ, Spencer, KA, Froud, DM, Raskin, J and Thase, ME (2008) A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder. Journal of Psychiatric Research 42, 2234.
Roy-Byrne, P (2015) Translating research to practice: too much research, not enough practice? Depression and Anxiety 32, 785786.
Ruscio, AM, Hallion, LS, Lim, C, Aguilar-Gaxiola, S, Al-Hamzawi, A, Alonso, J, Andrade, LH, Borges, G, Bromet, EJ, Bunting, B, Caldas, DAJ, Demyttenaere, K, Florescu, S, de Girolamo, G, Gureje, O, Haro, JM, He, Y, Hinkov, H, Hu, C, de Jonge, P, Karam, EG, Lee, S, Lepine, JP, Levinson, D, Mneimneh, Z, Navarro-Mateu, F, Posada-Villa, J, Slade, T, Stein, DJ, Torres, Y, Uda, H, Wojtyniak, B, Kessler, RC, Chatterji, S and Scott, KM (2017) Cross-sectional comparison of the epidemiology of DSM-5 generalized anxiety disorder across the globe. JAMA Psychiatry 74, 465475.
Schneier, FR, Belzer, KD, Kishon, R, Amsel, L and Simpson, HB (2010) Escitalopram for persistent symptoms of generalized anxiety disorder after CBT: a pilot study. Journal of Nervous and Mental Disease 198, 458461.
Starcevic, V (2015) Generalized anxiety disorder: psychopharmacotherapy update on a common and commonly overlooked condition. Australasian Psychiatry 23, 338342.
Tian, PSO (2007) A Group Cognitive Behaviour Therapy Program for Anxiety, Fear and Phobias. Australia: Toowong Private Hospital.
Toghanian, S, Dibonaventura, M, Jarbrink, K and Locklear, JC (2014) Economic and humanistic burden of illness in generalized anxiety disorder: an analysis of patient survey data in Europe. ClinicoEconomics and Outcomes Research 6, 151163.
Ware, JJ, Kosinski, M and Keller, SD (1996) A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Medical Care 34, 220233.
Weissman, MM (2015) The institute of medicine (IOM) sets a framework for evidence-based standards for psychotherapy. Depression and Anxiety 32, 787789.
Wetherell, JL, Petkus, AJ, White, KS, Nguyen, H, Kornblith, S, Andreescu, C, Zisook, S and Lenze, EJ (2013) Antidepressant medication augmented with cognitive-behavioral therapy for generalized anxiety disorder in older adults. The American Journal of Psychiatry 170, 782789.
Wetherell, JL, Stoddard, JA, White, KS, Kornblith, S, Nguyen, H, Andreescu, C, Zisook, S and Lenze, EJ (2011) Augmenting antidepressant medication with modular CBT for geriatric generalized anxiety disorder: a pilot study. International Journal of Geriatric Psychiatry 26, 869875.
Wong, SY, Mak, WW, Cheung, EY, Ling, CY, Lui, WW, Tang, WK, Wong, RL, Lo, HH, Mercer, S and Ma, HS (2011) A randomized, controlled clinical trial: the effect of mindfulness-based cognitive therapy on generalized anxiety disorder among Chinese community patients: protocol for a randomized trial. BMC Psychiatry 11, 187.
Yalom, ID (1995) The Theory and Practice of Group Psychotherapy, 4th Edn. New York: Basic Books.
Yuan, M, Zhu, H, Qiu, C, Meng, Y, Zhang, Y, Shang, J, Nie, X, Ren, Z, Gong, Q, Zhang, W and Lui, S (2016) Group cognitive behavioral therapy modulates the resting-state functional connectivity of amygdala-related network in patients with generalized social anxiety disorder. BMC Psychiatry 16, 198.


Related content

Powered by UNSILO

The efficacy of group cognitive-behavioural therapy plus duloxetine for generalised anxiety disorder versus duloxetine alone

  • Zhi-Juan Xie (a1), Nan Han (a2), Samuel Law (a3), Zhi-Wen Li (a4), Shu-Yan Chen (a5), Ju-Ping Xiao (a6), Yi Zhang (a6), Bing-Ling Gao (a7), Si-Si Jiang (a7), Hui-Min Gao (a7) and Xue-Bing Huang (a7)...


Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.